18F-FDG PET/CT in Patients with Parenchymal Changes Attributed to Radiation Pneumonitis
Open Access
- 1 October 2018
- journal article
- research article
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 27 (3) , 107-112
Abstract
Radiation pneumonitis (RP) can be an adverse complication of radiotherapy (RT) and can limit the application of the already planned radiation dose. It is often associated with RT of lung carcinoma and is occasionally caused by radiation therapy of breast carcinoma and lymphomas located in the mediastinum. Positron emission tomography/computed tomography (PET/CT) emerges lately as a prospective modality for early diagnostics of RP. The aim of this study was to summarize the initial data from diagnostic application of PET/CT in patients suspicious of RP and to derive criteria, which can help differentiate RP from early recurrence of the disease and/or residual tumor. The current study included 23 patients who had metabolic (PET) and anatomical (CT) changes consistent with RP. We additionally defined metabolic activity (SUVmax) in the lung parenchyma of 20 patients without RT. All patients had increased metabolic activity in the lung parenchyma involved in the irradiated area with a mean SUVmax 3.45 (ranging between 1 and 7.1). The control group had a physiological background metabolic activity-SUVmax 0.61 +/- 0.11. Metabolic changes in patients suspicious of RP involved diffusely increased metabolic activity coinciding with the anatomical changes in the irradiated area. Three out of 23 patients had a proven recurrence of the primary neoplastic process in the irradiated area. The metabolic changes in those patients involved an increase in metabolic activity at follow-up or lack of tendency towards normalization after chemotherapy, which implied the existence of viable tumor cells. Our initial experience in the diagnostic application of 18F-FDG PET/CT in patients suspicious of RP allows us to summarize the following: PET/CT is a reliable imaging modality in the diagnostics of RP. Through its sequential use, we can differentiate inflammatory changes related to RP from early recurrence of the primary neoplastic process.Keywords
This publication has 33 references indexed in Scilit:
- Prediction of radiation pneumonitis in lung cancer patients: a systematic reviewJournal of Cancer Research and Clinical Oncology, 2012
- Chemotherapy Significantly Increases the Risk of Radiation Pneumonitis in Radiation Therapy of Advanced Lung CancerAmerican Journal of Clinical Oncology, 2011
- Radiation Pneumonitis: Local Dose Versus [18F]-Fluorodeoxyglucose Uptake Response in Irradiated LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and preventionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Early FDG-PET imaging after radical radiotherapy for non–small-cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Radiation-induced lung injurySeminars in Radiation Oncology, 2003
- Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancerEuropean Respiratory Journal, 1999
- Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- CT appearance of acute radiation-induced injury in the lungAmerican Journal of Roentgenology, 1988
- Irradiation damage to the lungJournal of Thoracic Imaging, 1987